Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income
Growth 1st Quarter- Division and Corporate Holdings Update
Company Divisions Continue to Expand by Investing in Local Manufacturers,
Distributors, Brands and Dot.Com's
SAN DIEGO, April 4, 2013
SAN DIEGO, April 4, 2013 /PRNewswire/ -- Medical Marijuana Inc (OTC Pink:
MJNA) is pleased to inform shareholders that all Company divisions are healthy
and foresee increasing revenues from overall operations. With the close of the
first quarter of 2013, the Company has seen its revenue and net income
increase significantly over the prior quarter. Updates are provided for each
of our portfolio companies and investments as we enter into the second quarter
– where we expect explosive growth, fueled by new products coming onto the
market, further market penetration, product awareness through extensive
advertising with the companies first ever significant print-television and
internet campaigns, as well as with key marketing and distribution agreements
with non-industry related distribution companies.
Medical Marijuana Inc. has spent years developing its portfolio of products
and services. This April, the company launches more innovative products and
services than it has combined since its inception over four years ago. This
month sets the stage and tone for it's over the counter products.
Update on current events-
CanChew Biotechnologies – has two developmental product arms to bring the
cannabinoid based chewing gum to market. In the United States the CanChew
Advantage Chewing gum will be available on an over the counter basis and
online and without prescription or the need for a medical marijuana
recommendation\card. Each piece will contain approximately 7 mg of
naturally-derived CBD to provide health and wellness benefits to consumers.
The company has spent considerable amounts of resources to develop this
product and will be launching sales later this month.
Canchew successfully carried out its soft launch, as well as its free product
trial and market survey in December of last year. The free product trial and
market survey proved invaluable with its anecdotal feedback and survey
information. The company had over 1500 applicants for the free product trial
and for those who participated in the free product trial we will have a "thank
you" in the form of a special twelve month subscription discount.
The company has been in negotiations for the distribution and marketing rights
with several regional, national and international firms who have sought out
potential licensing for territorial distribution.
In Europe a form of the gum, yet to be officially named, will undergo clinical
testing this summer as one of the stages necessary for eventual European FDA
approval. This medication will consist of a combination of cannabinoid based
compounds. The indications for use would include patients with chronic pain,
muscular spasticity from multiple sclerosis, and nausea management from side
effects of chemotherapy in cancer patients. The company has allocated this
year twelve ($12m) million dollars in company equity to secure the clinical
development of this product.
Rebranding of CanChew Biotechnologies Corporate Website to be completed in
April, which includes: The clinical development path with timelines and
interactive update modules, additional and expanded research library.
Rebranding and launch of the Canchew over the counter product sales and
informational website, which includes: Canchew Store front and shopping carts,
expanded social media and blog components, store availability tracker and
locator, additional subscription options for clients in need of a larger
supply of Canchew advantage CBD chewing gum.
Canipa Holdings – Set up in 2012 to handle the marketing, sales and
distribution of Medical Marijuana Inc.'s portfolio of products throughout
Europe and the European Union Trade Zone participant counties. This year we
have seen medical marijuana being legalized in Italy and the Czech Republic,
with nearly a dozen more countries in discussion of legalization for medical
and\or recreational use. The company has set up a distribution network of
pharmacies, clinics, wellness centers and retail stores that will allow us to
offer our products to this developing market.
Canipa has finalized its terms for marketing, sales and manufacturing for 20
plus of its products for the EU and US markets. Of these products, 22 have
along with the manufacturing agreements, received EU Certificate of Health
Safety Free Sale Certificates. This is one of the most significant
developments in the Medical Marijuana Inc. product development. These products
will be available through our entire pipeline of distribution and will over
the coming quarters cross promote and develop brands for the US\EU markets
that address different consumer audiences and demographics.
Company launching its corporate and sales sites online. These sites will
initially have the EU approved products for sale on them, but will be rapidly
focus on integrating our entire portfolio of MJNA products.
The company is in negotiations with senior level political lobbyist in regards
to additional product approvals, as well as working with them to educate the
regulatory authorities on the use of cannabis based products. The company is
actively pursuing with these regulatory authorities the integration of MJNA
services in the fields of Seed to sale tracking, compliance, grow
technologies, packaging, process, testing and product licensing.
HempMeds – HempMeds was established to develop online platforms for the
marketing and sales of cannabis\hemp based consumer products. The company has
been in development of its platform and actively acquiring IP, additional
online properties, marketing and awareness partners for the past two years.
The company recently finished a transaction with RabbitHoleTechnologies to
license and develop through a series of linked back end database platforms
with more than 1700 online properties and counting. These 1700 plus properties
truly gives the company a significant advantage when it comes to marketing and
sales of products in our verticals. The sites are managed real time with a
database user interface, that allows all 1700 plus sales sites to be updated
on pricing, news and many other features at a simple managers interface, which
drastically saves capital and time, while dramatically increasing efficiency,
tractability and our ability to quickly launch products. The company believes
HempMeds has the ability to create groundswells within the cannabis and hemp
industry online product sales and marketing community.
These online properties serve many roles for MJNA and its brands:
1^st. It insulates competitors from entering our selected markets, by not
allowing them to have specialty search term\names and domains.
2^nd. It surrounds the competition with like kind website and landing page
feeder sites to direct traffic away from competitors websites and directly to
our informational and sales sites.
3^rd. It builds brand credibility for our company and pipeline of products.
This is accomplished by the simple volume and density of our selected product
and services search terms\ domain name combinations which lead back to our
sales sites. When a client looks to purchase CBD Products, as an example we
not only own that dot.com, but also wheretofindCBDProducts.com, as well as
many other key search term dot.com's. This leads to the company's advantage
and significant position for online product rankings and sales.
4^th. When someone looking to enter the market we are in, wants to launch a
product, and googles or finds that those dot.com's are taken and\or that the
page rankings are saturated with a company's sales and informational sites
those competitors will have some either look at a different marketing platform
(like ours) or look to compete with high costs advertising and awareness
The company will launch the websites, landing pages and product awareness
campaigns in conjunction with the announcements this month of product
KannaLife Sciences – Medical Marijuana Inc. continues to expand its ever
growingportfolioof innovative businesses and investments. Our newest
partnership with KannaLife Sciences lends a perfect fit for the Medical
Marijuana Inc. family of companies. KannaLife has spent years in the
development of standardization in packaging for cannabis based products.
Standardization of packaging for cannabis based products is not just a need
but a necessity. The company looks to set the standard in which the industry
will adapt and develop from. Over the coming months KannaLife will update the
industry on its packaging and product development.
KannaLife was recently awarded an Exclusive License Agreement With National
Institutes of Health – Office of Technology Transfer ("NIH-OTT") for the
Commercialization of U.S. Patent 6,630,507, "Cannabinoids asAntioxidantsand
Neuroprotectants" (the "'507 Patent"). The Companies are expected to soon
announce clinical development plans for a pharmaceutical medication based on
cannabinoids for the indication of Hepatic Encephalopathy.
The company believes KannaLife will be a leader in several key markets. First,
in the development in cannabinoid based pharmaceutical drugs. Second, the
standardization of packaging within the cannabis products industry. Third,
with it's over the counter cannabis based products. The company has a strong
management team in place with the vision, foresight and skillset that MJNA
looks for in its investments.
To learn more visitwww.KannaLife.com
PhytoSphere Systems LLC – is the worlds leading cannabinoid based
bio-technology Company. The company recently entered into an agreement with
CannaVest Corp (OTC:CANV) for the rights to use its brand name PhytoSphere
Systems, along with the outsourcing to CannaVest its hemp facility
cultivation, management and processing. The company is still owned eighty
(80%) percent by Medical Marijuana Inc., and as part of the transaction MJNA
became a significant shareholder in CANV.
PhytoSphere Systems will still play a significant role in the company's
overall game plan, with the licensing and outsourcing to CannaVest, the
company is able to save nearly ten (10M) million dollars of additional
infrastructure and development costs in the first two quarts of this year
alone. In addition to saving a significant amount of capital, the company was
able to streamline its corporate operations by not having its focus diverted
by a multi-country multi-continent highly management intensive business, while
still allowing MJNA and its subsidiaries a constant supply of these high
quality ingredients, just above manufacturing and infrastructure costs and
well below wholesale and retail pricing.
As the demand for CBD-based products continues to grow, PhytoSphere is
constantly expending their operational capacity to meet this demand.
Internally, the company is expected to deliver several hundred kilograms of
raw Hemp CBD oil this quarter to Medical Marijuana Inc. and the family of
PhytoSphere will offer its raw materials to the open market starting May 1^st
2013. With this raw materials sales launch, the company will launch its
updated corporate information and sales sites, where customers can purchase a
variety of products with several financing options for large scale wholesale
These products consist of the following:
1.High CBD hemp Oil Standard product
2.CBD hemp oil with concentrations from 20-80%
3.Custom order concentrations and viscosities
4.Mico-encapsulated CBD oil powders with custom concentrations
5.White label product manufacturing
6.CBD hemp Vapor Oil, for e-cigarettes and vaporizers
7.CBD hemp oil in the acid form or that has gone through the decarboxylation
8.Hemp Protein powder
9.Hemp Seed Oil
10.Hemp Stock Oil
11.Hemp Oil Blends, standard and custom
12.Hemp oil and other custom product blends and manufacturing
The company will also provide the following services:
2.Custom product formulation
3.Custom label and packing design
4.Hemp cultivar standardized reference database
5.Custom and Contract hemp farming
6.Seed to sale, full scale site development, management and training
7.Capital investments in new and existing brands within our industry
8.Toll processing, packaging and logistics for raw materials and products
9.Research and Development
PhytoSphere is in process of manufacturing six times the amount of oil it
produced last year.
Company is expanding its warehouses, processing, manufacturing and logistics
facility in the United States (California) to handling expanded volume.
Company produced its highest concentration of CBD oil this last quarter and
has expanded its processing abilities to create a specialty high grade stable
product aptly name "Real Scientific Oil" and sister brand "Harlequin CBD Oil",
which websites and sales sites will launch this month.
Red Dice Holdings – established as a holding company, Red Dice owns the
formulas, equipment, brands and intellectual property of the Dixie brand of
products which includes Dixie, Dixie Botanicals, Dixie Elixir's, Dixie
Edible's . They are involved in the distribution the Dixie Botanical brand of
CBD-infused products. Launched in September 2012, Red Dice continues to be a
leader in the industry with CBD-based health and wellness products as well as
with "industry" consumer products. The company is located in Denver Colorado
and has a manufacturing facility, research and development staff for the
development of cannabinoid based products. The company has a portfolio of over
70 products that ranges from CBD infused capsules and salves all the way to
cannabinoid infused mints and drinks.
The Dixie brand and its products are one of the worlds most recognized brands
within the cannabis industry. It has achieved this through and amazing team of
people who are dedication to high quality, innovative and consistent products.
The company has built not only a significant foothold in its market
(addressing 90% of the addressable market) but has built a solid foundation
for product manufacturing, sales and distribution. The Dixie platform and
value not only come from its brand, but also within its distribution pipeline.
Dixie and its management team have gotten a significant amount of press. For
more information on this please click here.
The company is rapidly expanding its brand to other high growth markets.
The company is launching additional products this quarter.
Dixie is to celebrate its 3^rd year anniversary at the end of April.
Wellness Managed Services – is engaged in the management, capitalization and
development of Health & Wellness facilities throughout North America.
Presently the Company is engaged in negotiations and discussions about
expanding the scope of clinics and facilities under management.
Is finalizing key distribution agreements within its network of wellness
facilities to aid in the marketing and sales of MJNA portfolio products and
The company has been working with international pharmacies and clinics to
educate them on the value of CBD based products.
Updated and rebranded website to launch this month.
"I would like to thank our team and our loyal shareholders for their continued
support. This is an exciting time for the company. Our team has been working
for years to be in the position we are today. We are very excited to update
shareholders on our new innovative products such as 'cbd vaporizer' our 'pet
emporium' and cbd based pet products to mention just a few. I encourage all of
our shareholders to sign up for our informational newsletter and email alerts,
we will be offering some exciting shareholder product promotions this month,"
stated Michelle Sides, Chairman and Chief Operating Officer.
About KannaLife Sciences
KannaLife Sciences ("KannaLife"), is a late stage bio-pharmaceutical and
phyto-medical technology company. We were created to develop natural,
phyto-medical products to be used inhealth and wellnessregimens. We are also
involved in the research and development of novel new therapeutic agents to be
used as transport carriers for other compounds seeking to break the
blood/brain barrier as well as our own compounds to be used for the treatment
and prevention of oxidative and neuro-toxic stresses born from a variety of
ailments and illnesses. For more information, please visit the company's
About PhytoSPHERE Systems
PhytoSPHERE Systems is the world's leading cannabinoid based biotechnology
company that develops and builds technology specifically for the cannabis
industry. This includes the research, development and production of specialty
cannabis cultivars. The company acquires, develops and manages traditional
cannabis agricultural facilities, as well as produces cannabinoid based high
value oil, extracts and products for the wholesale and retail markets.
About Dixie Botanicals
Dixie Botanicals offers innovative hemp oil products for health conscious
consumers. Our formulation experts include scientists, clinical herbalists and
nutritionists, who work to integrate our hemp oil into a variety of beneficial
and uniquely effective over-the-counter (OTC) products– bothdietary
supplementsand a topical balm. For more information, please visit the
For additional information and media coverage of Dixie Elixirs and Botanicals
click on any of the links below:
Fast Company "Innovation Agents"
60 Minutes "Rocky Mountain High Segment"
60 Minutes "Overtime" segment
Newsweek October 22 Cover Story, "The New Pot Barons"
Newsweek Cover Story Photo Gallery
PBS / WBUR
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their
integrity and entrepreneurial spirit. We strive to create awareness within
our industry, develop environmentally friendly, economically sustainable
businesses, while increasing shareholder value. For more information, please
visit the company's website at: www.MedicalMarijuanaInc.com.
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. to be materially different from the statements made
Medical Marijuana, Inc.
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana, Inc.
Press spacebar to pause and continue. Press esc to stop.